Clinical Trials Logo

Clinical Trial Summary

In competitive sport, it is illegal to manipulate erythropoiesis. Manipulated erythropoiesis can indirectly be identified by atypical fluctuations in key haematological variables. However, this method also has limitations and as it is known that some athletes still manipulate erythropoiesis it is necessary to develop new and more sensitive detection methods. The primary purpose of the study is to examine the importance of altered erythropoiesis for surface and intracellular erythrocyte proteins, the number of immature reticulocytes, and for the haematological characteristics of the erythrocyte, such as volume, haemoglobin concentration and concentration of glycosylated haemoglobin, to assess whether these can be used to identify changed erythropoiesis. Furthermore, the aim is to examine whether these parameters are affected by freezer storage of erythrocytes.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05833477
Study type Interventional
Source University of Copenhagen
Contact
Status Completed
Phase N/A
Start date October 28, 2022
Completion date December 16, 2022

See also
  Status Clinical Trial Phase
Completed NCT01187108 - Study of Cobalt's Role in Excessive Erythrocytosis Among High Altitude Dwellers in Cerro de Pasco, Peru Phase 1/Phase 2
Completed NCT04751292 - HIGH Altitude CArdiovascular REsearch Latin America Population Study
Terminated NCT05118048 - StatStrip Lactate, Hemoglobin, and Hematocrit Meter in Whole Blood
Withdrawn NCT02548117 - H-36731: Finasteride in Management of Elevated Red Blood Cells Phase 3